ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,889.25
6.37%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.045
0.00%
Brent Oil
82.765
-1.03%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. IGM Biosciences Inc (IGMS)

  7. IGM Biosciences Inc (IGMS) ニュース

IGMS IGM Biosciences Inc

10.07
0.64 (6.79%)
取引時間後
最終更新日： 06:55:51
15分遅延
名称 銘柄コード 市場 種別
IGM Biosciences Inc IGMS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.64 6.79% 10.07 06:55:51
始値 安値 高値 終値 前日終値
9.73 9.72 10.19 10.07 9.43
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1721:30GLOBEIGM Biosciences Announces Refocusing of Sanofi Collaboration
2024/4/1020:00GLOBEIGM Biosciences to Present at the Stifel 2024 Virtual..
2024/3/0806:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0806:10EDGAR2Form 8-K - Current report
2024/3/0806:10GLOBEIGM Biosciences Announces Fourth Quarter and Full Year 2023..
2024/3/0609:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0121:00GLOBEIGM Biosciences to Present at the Guggenheim Healthcare..
2024/1/0823:00EDGAR2Form 8-K - Current report
2024/1/0410:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0408:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0408:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0321:00GLOBEIGM Biosciences to Present at the 42nd Annual J.P. Morgan..
2023/12/1609:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1609:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1609:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1407:36EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1407:33EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1407:30EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1407:27EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0906:05EDGAR2Form 8-K - Current report
2023/12/0606:01GLOBEIGM Biosciences Announces Strategic Pipeline Prioritization..
2023/12/0209:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0209:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0209:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0119:32PRNUSBulletin from Extraordinary General Meeting in Medivir AB..
2023/11/3010:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/3010:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/3010:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2814:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/2116:48PRNUSMedivir to present at the Erik Penser Bank Company Event
2023/11/1407:08EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/1406:10EDGAR2Form 8-K - Current report
2023/11/1406:10GLOBEIGM Biosciences Announces Third Quarter 2023 Financial..
2023/11/1406:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0721:00GLOBEIGM Biosciences to Present at Two Upcoming Investor..
2023/10/0608:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0608:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/0520:29PRNUSFostrox + Lenvima continues to show promising tumor control..
2023/10/0409:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0408:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0408:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0408:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0405:14EDGAR2Form 8-K - Current report
2023/10/0405:05GLOBEIGM Biosciences Announces Retirement of Chairman Michael..
2023/10/0305:27EDGAR2Form 144 - Report of proposed sale of securities
2023/9/0620:00GLOBEIGM Biosciences to Present at the Morgan Stanley 21st Annual..
2023/8/0405:13EDGAR2Form 8-K - Current report
2023/8/0405:10GLOBEIGM Biosciences Announces Second Quarter 2023 Financial..
2023/8/0405:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/2005:13EDGAR2Form SC 13D/A - General statement of acquisition of..

最近閲覧した銘柄

NASDAQ
IGMS
IGM Biosciences
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有